Randomized clinical trial: an assessment of acupuncture on specific meridian or specific acupoint vs. sham acupuncture for treating functional dyspepsia

Functional dyspepsia is a common gastrointestinal disorder characterized by epigastric pain, burning, early satiety, and postprandial fullness, affecting 11-29% of the population worldwide. Although it is not life-threatening, it imposes a significant impact on patients' quality of life and represents a substantial economic burden on society. Conventional pharmacologic treatments include antacids, prokinetics, antidepressants, and anxiolytics, but their benefits remain limited and many patients fail to achieve satisfactory improvement in quality of life. This context makes alternative therapies, especially acupuncture, an attractive option for both patients and healthcare providers.

This randomized controlled trial was conducted in eight outpatient hospital departments in China between April 2008 and October 2009, representing one of the largest clinical trials involving acupuncture for functional dyspepsia. The principal aim was to determine the efficacy of acupuncture compared with itopride (a prokinetic drug), to investigate the specific effect of acupoints compared with non-acupoints, and to explore whether specificity exists between different acupoints and meridians. The methodology enrolled 712 eligible patients aged 18-65 years, diagnosed with functional dyspepsia per the Rome III criteria. Participants were randomly distributed into six groups: Group A used specific points on the stomach meridian (ST-42, ST-40, ST-36, ST-34), classically considered effective for digestive problems; Group B used nonspecific points on the same meridian (ST-38, ST-35, ST-33, ST-32); Group C used specific points in the dorsal and abdominal regions (BL-21, CV-12); Group D used points on the gallbladder meridian (GB-40, GB-37, GB-36, GB-34); Group E received sham acupuncture at nonspecific points; and Group F was treated with itopride 50 mg three times daily.

Treatment consisted of 20 sessions over 4 weeks (five consecutive sessions per week with a 2-day interval), followed by a 12-week follow-up period. All acupuncture groups received electrostimulation (2/100 Hz) at 0.5-1.5 mA for 30 minutes per session. Primary outcomes were measured using the Dyspepsia Symptom Index, while secondary outcomes included changes in quality of life via the Nepean Dyspepsia Index (NDI). Results revealed significant differences between groups.

Group A (specific stomach meridian points) had the highest response rate at 70.69%, significantly superior to sham acupuncture (34.75%) and itopride (55.46%). Among the true acupuncture groups, Group A also outperformed the others: Group B (50%), Group C (51.75%), and Group D (55.46%). All groups showed improvement in dyspeptic symptoms and quality of life by the end of treatment, with benefits maintained during 4 and 12 weeks of follow-up. Subgroup analysis revealed that Group A was particularly effective for early satiety in postprandial distress syndrome (45.6% vs.

14.1-29.3% in other groups). Regarding safety, only 10 adverse events were reported in the acupuncture groups (pain or hematoma at the needling site, gastric distention, and mild fainting), plus one case of mild headache in the itopride group. The clinical implications of this study are substantial. First, it confirms the efficacy of acupuncture for functional dyspepsia, providing robust evidence to support its clinical application.

Second, it demonstrates that acupoint specificity exists, with classic stomach meridian points showing therapeutic superiority and partially validating traditional Chinese medicine principles. Third, it suggests that acupuncture may be superior to conventional medications in some respects, particularly in improving quality of life. The study establishes that proper point selection is essential to therapeutic success — simply inserting needles at any location is not sufficient. Limitations include the absence of a waitlist control group, which could have better distinguished the effects of self-healing.

Additionally, patients' anxiety status was not measured, which can influence assessment outcomes. The lack of observation of gastrointestinal hormone levels or motility limited understanding of mechanisms of action. The study was also conducted exclusively in a Chinese population, which may limit generalizability of the results to other culturally distinct populations.